obstructive coronary artery disease and angina, and potentially may cause myocardial ischemia.
was measured prior to adenosine injection.
After a 5-minute equilibration period, baseline APV was recorded, followed by coronary angiography using nonionic contrast medium (Omnipaque, Winthrop Laboratories). Acetylcholine (Iolab Pharmaceuticals) at concentrations of 10 -6 , 10 -5 , and 10 -4 mol/L (to achieve estimated final blood concentrations in the coronary bed of 10 -8 , 10 -7 , and 10 -6 mol/L) was infused for 3 minutes at each concentration. Doppler measurements and coronary angiography were obtained after each infusion. The infusion was terminated when the largest dose of acetylcholine (10 -4 mol/L) was reached. Infusions were performed with a Harvard pump to maintain infusion rates at less than 1% of estimated CBF. Nitroglycerin (Abbott Laboratories) was then injected as an intracoronary bolus (200 µg) through the guiding catheter to evaluate endothelium-independent coronary vasoactive response of vessels >200 µm in diameter. 24 When the maximal effect of nitroglycerin was attained, measurements were obtained, and adenosine was injected again to determine the endothelium-independent coronary flow reserve ratio under conditions of epicardial vasodilation.
At each time interval, APV was recorded, followed by coronary angiography. The angles, skew rotation, and table height were kept constant during the procedure. In addition, the distances between the image intensifier and the x-ray tube to the patient were kept constant. CAD was measured by an independent investigator, unaware of other data (ie, Doppler flow and sestamibi perfusion data), using a computerbased image analysis system, as previously described. 25 The measurements were performed in the segment 5 mm distal to the tip of the Doppler wire. For each time interval, the diameter was measured in the same segment. CBF was calculated from the Doppler-derived time velocity integral and vessel diameter, as previously described 26 :
Following the intracoronary infusions, intravascular ultrasound of the LAD was performed with a Hewlett-Packard imaging system as described previously 27 28 to confirm the absence of significant obstructive coronary artery disease. Continuous images were recorded throughout the LAD on a 0.5-in videotape for off-line analysis. A special effort was made to keep the ultrasound catheter parallel to the long axis of the vessel lumen. Five to six segments of the LAD were identified in the videotape recording of the ultrasound images by the digital counter, and the exact position of the ultrasound catheter in relation to the artery was recorded on cinefilm at each position. The location of the catheter seen on the cinefilm of each segment was used to correlate the identified ultrasound image with the angiographic segment.
An off-line computer-interactive analysis system was used to digitize the intracoronary ultrasound video images onto a 256x256-bit matrix. Standard calibration markers directly from the ultrasound images were used for calibration of absolute measurements. This method and histopathological correlation have been validated for interpretation of intravascular ultrasound images. 13 29 All measurements were made in end diastole and measured at the media-adventitia interface. Measurements of CAD were averaged from two orthogonal planes. The segment was excluded if the two measurements of diameter differed by more than 20% to avoid measuring an ellipsoid image. 30 All measurements were made by an observer with no knowledge of the Doppler or angiographic findings.
Sestamibi Imaging
Imaged acquisition, processing, and interpretation have been reported in detail previously. 16 17 31 32 In brief, all patients received an intravenous injection of 20 to 30 mCi of 99m Tc sestamibi just prior to the infusion of the highest dose of acetylcholine. Tomographic imaging was performed within 2 hours. Images were acquired using a rotating gamma camera with an all-purpose collimator. Processing and reconstruction were performed using standard back-projection algorithms and a Ramp-Hanning filter. Circumferential count profiles were generated for five representative short-axis slices of the left ventricle extending from apex to base. The images were interpreted by an investigator (R.J.G.) blinded to the results of acetylcholine infusion. The patients were divided into three groups on the basis of results of sestamibi imaging: group 1, perfusion defect outside of the LAD distribution; group 2, no perfusion defect; group 3, perfusion defect within the LAD distribution. Since sestamibi SPECT imaging provides a measure of relative perfusion, the presence of a perfusion defect outside of the LAD distribution would be consistent with an increase in flow in the LAD. In contrast, a perfusion defect within the LAD distribution would be consistent with a decrease in flow in the artery.
Data Analysis
The maximal effect of acetylcholine infusion is expressed as percent change (mean±SEM) in CAD (% CAD) and in CBF (% CBF) relative to baseline. Differences between groups were analyzed using one-way ANOVA. Differences in baseline angiographic and clinical characteristics were analyzed using one-way ANOVA and the Fisher exact test. A value of P<.05 was accepted as significant.
The study population included 20 patients, 10 men and 10 women, ranging in age from 31 to 67 years. Of this group, 30% were smokers and 20% had hypertension. The mean plasma cholesterol level for the whole group was 204±15 mg/dL. There were no significant differences in baseline demographics and in risk factors for coronary artery disease between the three groups ( Table 1 ). The maximal percent area stenosis of the LAD was similar for all groups. There were no significant differences in calculated area stenosis as assessed by quantitative coronary angiography and intravascular ultrasound. All patients had mild coronary atherosclerosis as assessed by quantitative coronary angiography, with a similar distribution among the three major epicardial arteries for the three groups (Table 2 ) . Intracoronary injection of normal saline increased the APV insignificantly in all patients. The endothelium-independent coronary flow reserve, as assessed by intracoronary injection of adenosine, was similar in all groups (3.2±0.5, 2.9±0.7, and 3.0±0.4 for groups 1 through 3, P=NS). Similar values were attained when adenosine was injected after nitroglycerin (3.4±0.4, 3.2±0.8, and 3.1±0.5 for groups 1 through 3, respectively, P=NS).
Results

Top
There were significant differences, however, in the maximal response to acetylcholine between the three groups ( Figure ) . The effects of acetylcholine on CAD and CBF at the three doses are presented in Table 3 . In response to selective infusion of acetylcholine in the LAD, mean % CAD and % CBF of the LAD increased by as much as 25±5% and 241±46%, respectively, in patients with filling defects in the non-LAD distribution (group 1). In patients without myocardial perfusion defects (group 2), % CAD in the LAD decreased by as much as 26±5%, but % CBF increased by 54±17%. In patients with perfusion defects in the LAD distribution (group 3), both % CAD and % CBF in the LAD decreased by 35±5% and 51±14%, respectively. The % CAD in group 2 was significantly different from group 1 (P<.05) but similar to group 3 ( Figure ) . In addition, the % CBF in group 2 was significantly different (P<.05) from groups 1 and 3 ( Figure ) , as was the difference between groups 1 and 3.
There was no difference between the three groups in % CAD and % CBF in response to intracoronary nitroglycerin relative to baseline, indicating intact endothelium-independent coronary epicardial vasodilation.
To assess the incidence of perfusion defects during acetylcholine infusion among patients with coronary endothelial dysfunction, we used two criteria to define endothelial dysfunction. When defined as % CBF 0 in response to acetylcholine, 7 of 7 patients with endothelial dysfunction had perfusion defects in the LAD territory, as compared with 0 of 13 patients with % CBF>0. When defined as % CBF 50 in response to acetylcholine, 7 of 11 patients with endothelial dysfunction had perfusion defects in the LAD territory, compared with 0 of 9 patients with % CBF>50.
The current study demonstrates that coronary endothelial dysfunction in humans resulting in a decrease in CBF in the LAD (group 3) was associated with myocardial perfusion defects within the territory of the LAD by 99m Tc-sestamibi SPECT imaging. Coronary endothelial dysfunction with a reduction in CAD but an attenuated increase in CBF (group 2) was not associated with myocardial perfusion defects by 99m Tcsestamibi SPECT imaging. Normal endothelial function, characterized by an increase in CAD in response to acetylcholine infusion with a large increase in CBF (group 1), was associated with a perfusion defect outside the territory of the LAD by 99m Tc-sestamibi SPECT imaging, consistent with an increase in CBF in the LAD relative to other territories. These findings indicate that coronary vasoconstriction associated with endothelial dysfunction leading to a decrease in CBF may mediate myocardial perfusion defects suggestive of myocardial ischemia in humans.
Gould et al 33 previously showed that risk factor modification in patients with coronary artery disease improved myocardial perfusion. The significant improvement in myocardial perfusion assessed by positron emission tomography was associated with only mild changes in coronary artery stenosis. The current study supports these findings, underscoring the importance of the coronary microcirculation endothelial function in the regulation of myocardial perfusion. Our data show that the changes in CAD in response to acetylcholine do not accurately reflect changes in CBF. Acetylcholine may cause coronary epicardial and microvessel vasoconstriction in states of endothelial dysfunction. 6 7 8 9 10 11 12 13 14 15 However, despite the coronary epicardial vasoconstriction in response to acetylcholine in coronary endothelial dysfunction, CBF may be preserved or even increased. 8 10 12 13 14 15 In addition, although there is an interaction between endothelium-dependent and endotheliumindependent mechanisms, 34 our results underscore the possible dissociation between the two pathways at both the epicardial and microcirculation levels. All patients had an intact response to adenosine and nitroglycerin, reflecting preserved endothelium-independent pathways, yet the response to acetylcholine was abnormal in patients with endothelial dysfunction (groups 2 and 3). The results in patients with endothelial dysfunction and myocardial perfusion defects (group 3) demonstrate that myocardial perfusion defects may occur in the absence of impaired endothelium-independent mechanisms. coronary endothelial function has been suggested as a cause of acute myocardial infarction in patients with minimally obstructive disease. 35 These prior studies implicate impaired endothelial function as a possible cause of myocardial ischemia, although a causal relation between the response to acetylcholine infusion and myocardial ischemia was not established.
In a more recent report, transient perfusion defects were observed in a substantial proportion of patients with acetylcholine-induced coronary epicardial vasoconstriction injected with thallium during peak acetylcholine infusion. 36 The current study extends the findings of these prior studies, by demonstrating for the first time that acetylcholine-induced reductions in CBF may be temporally associated with regional myocardial perfusion defects suggestive of myocardial ischemia. Acetylcholine-induced reductions in CAD did not predict myocardial perfusion defects; epicardial CAD reduction occurred in a proportion of patients with endothelial dysfunction who had preserved CBF and no perfusion defects (group 2), indicating that the coronary resistance vessel vasodilation was effective in maintaining CBF in these patients.
Di Marco et al, 8 using intracoronary Doppler for the measurement of CBF, previously reported that CBF in response to acetylcholine infusion was reduced in only 35% of patients with coronary artery disease. However, CAD was reduced at the maximal concentration of acetylcholine in all but 3 of the patients. The authors concluded that there is a dissociation between the impairments of endothelium-dependent vasodilation of conductance and resistance vessels. Our findings support such a phenomenon. In patients with normal endothelial function (group 1), CAD increased by 25%, yet CBF increased by 241%, indicating that coronary vasodilation occurred at both the epicardial and the microcirculation levels. In patients with endothelial dysfunction but no perfusion defects (group 2), CAD decreased by 26%, yet CBF increased by 54%. These patients had epicardial endothelial dysfunction but retained the coronary microcirculation endothelium-dependent vasodilator capability. It is possible that the vasodilator response of the coronary microcirculation in these patients was not completely intact, and that even in the face of a 26% reduction in CAD, a more pronounced rise in CBF would have been attained had the microcirculation fully dilated. Myocardial perfusion defects consistent with myocardial ischemia were evident when both CAD and CBF were reduced (group 3). In these patients, the reduction in CBF (51%) was comparable to the reduction in CAD (35%). In contrast to patients in group 2, in whom a similar decrease in CAD had occurred but CBF had increased, CBF in patients in group 3 decreased, indicating that the microcirculation did not dilate. Thus, groups 1 through 3 may reflect intact, partially impaired, and impaired endothelium-dependent coronary microcirculation vasodilation, respectively.
Prior studies have demonstrated that coronary microvascular endothelial dysfunction may contribute to the reduced vasodilator reserve in patients with minimally obstructive coronary artery disease. Quyyumi and coworkers 15 demonstrated that patients with minimally obstructive coronary artery disease and depressed vasodilation in response to atrial pacing had reduced endothelium-dependent dilation with acetylcholine, presumably due to impaired coronary microcirculation vasodilation. Egashira and colleagues 13 reported that the vasodilator response of the coronary microcirculation is blunted in patients with minimally obstructive coronary artery disease and angina. In this study, we have shown that myocardial perfusion defects may occur in patients whose coronary microcirculation endotheliumdependent reserve is altered.
In the present study we did not prove that the perfusion defects associated with a reduction in CBF resulted in myocardial ischemia. Moreover, we did not prove that these defects occur spontaneously or during physiological stress in patients with endothelial dysfunction, explaining their symptoms. Nevertheless, given that an impaired response to acetylcholine is associated with thallium scintigraphic defects suggestive of myocardial ischemia in response to exercise, 2 these findings lend credence to the hypothesis that coronary vasoconstriction may occur in patients with coronary endothelial dysfunction, resulting in impaired blood flow and myocardial ischemia. To further support this hypothesis, additional studies during physiological stress should be done. Even those studies may not be conclusive, since the presence of perfusion defects during physiological stress does not necessarily imply that the underlying mechanism is endothelial dysfunction.
Patients with minimally obstructive coronary artery disease and chest pain present a difficult diagnostic and therapeutic challenge. 22 In our study, we demonstrate that coronary endothelial dysfunction may exist without myocardial perfusion defects, due to coronary microvessel dilation. Assuming that the endothelium-dependent response to acetylcholine reflects the response to stress, 2 the cause of symptoms in such patients is unclear, as CBF is not reduced. It is possible that nociceptive mediators are released during the coronary epicardial vasoconstriction. Indeed, endothelium-dependent vasodilators such as bradykinin are known to be cardiac algogenic substances. 37 In addition, nitric oxide attenuates the nociceptive effect of cholinergic stimulation. 38 Coronary endothelial dysfunction is characterized by reduced nitric oxide activity, 1 and hence these patients may have a lower pain threshold.
There are several limitations worth considering in interpreting our data. Our data were derived from a relatively small sample of highly selected patients referred to a tertiary-care center for the investigation of persistent chest pain. The proportion of patients with a decrease in CBF in response to acetylcholine may be different among patients being investigated for the cause of their chest pain in other settings. In addition, the blood flow velocities may be subject to some variability.
The treatment of coronary endothelial dysfunction is still investigational. Di Marco et al 8 have suggested that different mechanisms underlie the endothelial dysfunction of conductance and resistance coronary vessels. Moreover, the vasoactive properties of epicardial and microcoronary vessels may be substantially different. 39 The results of the present study indicate that the severity of the clinical manifestations of coronary endothelial dysfunction may be determined by the degree of involvement of the coronary microcirculation. Hence, the treatment of coronary endothelial dysfunction should also target the coronary microcirculation. 40 Circulation.. 1995; 91:2345 -2352 3. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ Jr, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med.. 1991; 325:1551 325: -1556 4. Gordon JB, Ganz P, Nabel KG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest.. 1989; 83:1946 -1952 5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med.. 1993; 329:2002 -2012 6. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis . J Am Coll Cardiol.. 1994; 23:833-843.[Abstract] 7. Penny WF, Rockman H, Long J, Bhargava V, Carrigan K, Ibriham A, Shabetai R, Ross J Jr, Peterson KL. Heterogenity of vasomotor response to acetylcholine along the human coronary artery. J Am Coll Cardiol.. 1995; 25:1046 25: -1055 8. Di Marco C, Strikwerda S, Gil R, de Feyter PJ, de Jaegere P, Serruys PW. Response of conductance and resistance coronary vessels to scalar-concentrations of acetylcholine: assessment with quantitative angiography and intracoronary Doppler echography in 29 patients with coronary artery disease. Am Heart J.. 1994; 127:514-531 . [Medline] 
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